Literature DB >> 15637419

Concentration of transforming growth factor beta2 in aqueous humor.

Naoki Yamamoto1, Koichiro Itonaga, Tohru Marunouchi, Kiyoyuki Majima.   

Abstract

The total transforming growth factor (TGF) beta(2) concentration in the anterior chamber aqueous humor of 96 cataract patients with ages ranging from 17 to 88 years was measured using ELISA to investigate the changes that occur with age, difference of axial length, difference of localization of opacification of the cataractous lens and complications with other eye diseases. It was found that the total TGF-beta(2) concentration (1) decreases with age, (2) shows slight changes with axial length, (3) has slight changes with difference of localization of opacification, (4) is significantly high in patients with concurrent open-angle glaucoma (p < 0.05), (5) is high in patients with complicating diabetes who have undergone panretinal photocoagulation for diabetic retinopathy (p < 0.05) and (6) is low in patients with atopic cataracts. There have been several reports on point 4 above, but none to date of the other points. These findings provide useful information on the intraocular activity of TGF-beta(2). Copyright 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15637419     DOI: 10.1159/000083019

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  33 in total

1.  Influence of race and age on aqueous humor levels of transforming growth factor-beta 2 in glaucomatous and nonglaucomatous eyes.

Authors:  Rupal H Trivedi; Matthew Nutaitis; David Vroman; Craig E Crosson
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

2.  Elevated transforming growth factor β1 in plasma of primary open-angle glaucoma patients.

Authors:  John Kuchtey; Jessica Kunkel; L Goodwin Burgess; Megan B Parks; Milam A Brantley; Rachel W Kuchtey
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-24       Impact factor: 4.799

Review 3.  Aqueous humor outflow: dynamics and disease.

Authors:  Uttio Roy Chowdhury; Cheryl R Hann; W Daniel Stamer; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 4.  Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis.

Authors:  Daisy Y Shu; Frank J Lovicu
Journal:  Prog Retin Eye Res       Date:  2017-08-12       Impact factor: 21.198

Review 5.  Monitoring Neurodegeneration in Glaucoma: Therapeutic Implications.

Authors:  Norimitsu Ban; Carla J Siegfried; Rajendra S Apte
Journal:  Trends Mol Med       Date:  2017-12-07       Impact factor: 11.951

6.  NQO1 downregulation potentiates menadione-induced endothelial-mesenchymal transition during rosette formation in Fuchs endothelial corneal dystrophy.

Authors:  Kishore Reddy Katikireddy; Tomas L White; Taiga Miyajima; Shivakumar Vasanth; Duna Raoof; Yuming Chen; Marianne O Price; Francis W Price; Ula V Jurkunas
Journal:  Free Radic Biol Med       Date:  2017-12-30       Impact factor: 7.376

Review 7.  The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure.

Authors:  John Kuchtey; Rachel W Kuchtey
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-12       Impact factor: 2.671

Review 8.  The many faces of the trabecular meshwork cell.

Authors:  W Daniel Stamer; Abbot F Clark
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

9.  Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure.

Authors:  Wan-Heng Wang; Loretta G McNatt; Iok-Hou Pang; J Cameron Millar; Peggy E Hellberg; Mark H Hellberg; H Thomas Steely; Jeffrey S Rubin; John H Fingert; Val C Sheffield; Edwin M Stone; Abbot F Clark
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

10.  Rho GTPase signaling promotes constitutive expression and release of TGF-β2 by human trabecular meshwork cells.

Authors:  Cynthia L Pervan; Jonathan D Lautz; Andrea L Blitzer; Kelly A Langert; Evan B Stubbs
Journal:  Exp Eye Res       Date:  2015-12-30       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.